GSA Capital Partners’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
+32,563
| New | +$224K | 0.02% | 1442 |
|
|
2024
Q4 | – | Sell |
-17,142
| Closed | -$61K | – | 1746 |
|
|
2024
Q3 | $61K | Sell |
17,142
-118,079
| -87% | -$420K | ﹤0.01% | 1513 |
|
|
2024
Q2 | $838K | Buy |
135,221
+120,059
| +792% | +$744K | 0.06% | 623 |
|
|
2024
Q1 | $143K | Buy |
+15,162
| New | +$143K | 0.01% | 1454 |
|
|
2022
Q4 | – | Sell |
-17,879
| Closed | -$145K | – | 1613 |
|
|
2022
Q3 | $145K | Sell |
17,879
-4,943
| -22% | -$40.1K | 0.02% | 1303 |
|
|
2022
Q2 | $112K | Buy |
+22,822
| New | +$112K | 0.02% | 1203 |
|